Advanced Enzyme Technologies announces ₹69.7 crore buyback
Advanced Enzyme Technologies (ADVENZYMES) filed a disclosure titled "Closure of Buyback". The company is valued at about ₹2,958 crore.
What happened
Advanced Enzyme Technologies (ADVENZYMES) filed a disclosure with the exchanges on 30 October 2026 at 07:15 PM titled "Closure of Buyback".
How big is it?
At ₹69.7 crore, the buyback is equal to about 2.4% of the company's market value of ₹2,958 crore.
Company snapshot
Advanced Enzyme Technologies is a small-cap company in the Healthcare sector, with a market value of about ₹2,958 crore.
The stock last traded at ₹264.2, against a 52-week range of ₹246.8–₹419 (37.0% below the high).
Before this filing the shares had moved −6.4% over the month and −16.2% over three months. Average daily turnover over the last 20 sessions was about ₹5.52 crore.
Promoters held 43.24% at the end of Q1 FY27, down 0.02% points from the previous quarter. Foreign institutions owned 26.71% and domestic institutions 4.78%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 186 | 39.9 | 3.57 |
| Q2 FY26 | 185 | 43.3 | 3.87 |
| Q3 FY26 | 172 | 42.5 | 3.8 |
| Q4 FY26 | 203 | 43 | 3.84 |
| Q1 FY27 | 190 | 37.1 | 3.31 |
What history shows
This is not the company's first buyback disclosure: BCEIE has at least 12 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 0.4% on average the next trading day and was down 2.4% on average after five days (10 filings with price data).
Across 7 similar disclosures by other Healthcare companies, shares moved +0.2% on average the next day and +1.5% over five days; 43% of them rose the next day.
Market-wide, 311 buyback filings with an impact score of 50 or more saw an average next-day move of +0.2%, with 56% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 27 Oct 2026 | Daily Report pursuant to Regulation 18(i) of the Buyback Regulations… | +1.3% | — |
| 26 Oct 2026 | Daily Report pursuant to Regulation 18(i) of the Buyback Regulations… | +3.0% | — |
| 23 Oct 2026 | Daily Report pursuant to Regulation 18(i) of the Buyback Regulations… | +5.0% | — |
| 22 Oct 2026 | Daily Report pursuant to Regulation 18(i) of the Buyback Regulations… | −2.6% | — |
What to watch
- 31 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Advanced Enzyme Tech buys 54,455 shares Oct 29, cumulative 24.10 lakh
- Advanced Enzyme Technologies Ltd. Share Price Live Today
- Advanced Enzyme Technologies (ADVENZYMES.NS) Slips 1.87% to ₹262.0 as Stock Retreats From Upper Range - Gap Down Bounce Plays
- Advanced Enzyme Technologies (NSE:ADVENZYMES): Why Is a Promoter Group Member Seeking Reclassification?
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.